Oncology Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Modicus Prime provides an AI Management System (AIMS) for pharmaceutical companies and contract development and manufacturing organizations (CDMOs) to validate, audit, and govern AI systems across their operations in compliance with FDA and other regulatory requirements.
AI & Machine LearningBiotechHealthtechSaaSLa Porte, US
Taylor Chartier(Founder & CEO)Davit Vardanyan(Director)
BoardRoger Chen(Director)in
PartnerBen Freeberg· solo GP
Co-investorsSilverton PartnersSmartGateVCTechstarsFrist Cressey VenturesPlug and Play Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.